表决情况：同意 10 票，反对 0 票，弃权 0 票。 A股股票代码：601336 A股股票简称：新华保险 编号：2023-045号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 第八届董事会第十次会议决议公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"公司"）于 2023 年 9 月 26 日以电 子邮件方式向全体董事发出第八届董事会第十次会议（以下简称"会议"）通知 和材料，会议于 2023 年 10 月 10 日在北京市以现场会议方式召开。会议应到董 事 10 人，现场出席董事 10 人，公司监事和部分高级管理人员列席了会议。会议 的召集、召开符合《中华人民共和国公司法》《新华人寿保险股份有限公司章程》 和《新华人寿保险股份有限公司董事会议事规则》的有关规定，所作的决议合法、 有效。 全体董事一致推举董事张泓主持本次会议，经与会董事审议和现场表决，形 成如下会议决议： 一、审议通过了《关于选举公司第八届董事会董事长的议案》，同意 ...

HKEX 分 史 文 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2023年9月30日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 新華人壽保險股份有限公司 第 8 頁 共 14 頁 FF301 v 1.0.2 FF301 2023年10月8日 呈交日期: l.法定/註冊股本變動 □ 不適用 | 1. 股份分類 | 普通股 | 股份類別 | H | 於香港聯交所上市(註1) | 륜 | + | | --- | --- | --- | --- | --- | --- | --- | | 證券代號 | 01336 | 説明 | | | | | | 多櫃檯證券代號 | | 説明 | | | | l | | 增加多櫃檯證券代號 | | | | | | | | □ 手動填寫 | | 法定/註冊股份數目 | | 面値 | 法定/註冊股本 | | | 上月底結存 | | | 1,034,107,260 RMB | 1 RMB | | 1,034,107,260 | | 增加 / 減少 (-) | | | | RMB | | | | 本月底結存 | | | 1,0 ...

| H | A | | --- | --- | | 股证券代码：01336 | 股证券代码：601336 | | H 股证券简称：新华保险 | A 股证券简称：新华保险 | | | 公告编号：2023-044 | | | 号 | 新华人寿保险股份有限公司 2023 年第二次临时股东大会决议公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存在任 何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整 性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一) 股东大会召开的时间：2023 年 9 月 25 日 (二) 股东大会召开的地点：北京市朝阳区建国门外大街甲 12 号新华保险大厦 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | | 52 | | --- | --- | --- | | 其中：A | 股股东人数 | 51 | | 境外上市外资股股东人数（H | 股） | 1 | | 2、出席会议的股东所持有表决权的股份总数（股） | | 1,652,636,248 | | 其中：A ...

中国北京建国门外大街 1 号国贸写字楼 2 座 12-14 层 100004 12-14th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com 北京市通商律师事务所 关于新华人寿保险股份有限公司 2023 年第二次临时股东大会之法律意见书 致：新华人寿保险股份有限公司 根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和 国证券法》(以下简称"《证券法》")、《上市公司股东大会规则》(以下简称"股 东大会规则")等相关法律、法规以及《新华人寿保险股份有限公司章程》(以下 简称"公司章程")、《新华人寿保险股份有限公司股东大会议事规则》(以下简称 "股东大会议事规则")的规定，北京市通商律师事务所(以下简称"通商")接受新 华人寿保险股份有限公司(以下简称"公司")的委托，指 ...

NEW CHINA LIFE INSURANCE COMPANY LTD. 01336 董事名單與其角色和職能 新華人壽保險股份有限公司董事會（「董事會」）成員載列如下： 執行董事 張 泓 董事會下設五個專業委員會，各專業委員會的組成如下： | | | 委員會 | | | 審計與關聯 交易控制 | 提名薪酬 | 風險管理與 消費者權益 | | --- | --- | --- | --- | --- | --- | --- | --- | | 董事 | | | 戰略委員會 | 投資委員會 | 委員會 | 委員會 | 保護委員會 | | 張 | 泓 | | M | M | | | | | 楊 | 毅 | | M | C | M | | | | 何興達 | | | | M | | | M | | 楊 | 雪 | | | | | M | M | | 胡愛民 | | | M | M | | | | | 李琦強 | | | | | M | M | M | | 馬耀添 | | | | | | M | M | | 賴觀榮 | | | M | M | M | | | | 徐 | 徐 | | | | M | C | M | | ...

新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"本公司"）董事会于 2023 年 9 月 18 日收到独立董事耿建新先生的辞职函，因任独立董事时间已满六年，根据相 关监管规定，耿建新先生向董事会提出辞去本公司独立董事、董事会审计与关联 交易控制委员会主任委员及提名薪酬委员会委员职务。 | A股股票代码：601336 | A股股票简称：新华保险 编号：2023-043号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 新华人寿保险股份有限公司 关于独立董事辞职的公告 根据中国证券监督管理委员会《上市公司独立董事管理办法》以及《新华人 寿保险股份有限公司章程》等相关规定，耿建新先生的辞职不会导致公司董事会 人数低于法定人数，不会导致独立董事人数少于董事会成员的三分之一或者董事 会专业委员会中独立董事所占比例不符合法律规定。 耿建新先生的辞职函自送达本公司董事会之日起生效，其辞职不影响本公司 董事会的正常运作。耿建新先生确认其与本 ...

上述原保险保费收入数据未经审计，提请投资者注意。 | A股股票代码：601336 | A股股票简称：新华保险 编号：2023-042号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 新华人寿保险股份有限公司 保费收入公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 根据中华人民共和国财政部《企业会计准则第 25 号——原保险合同》（财 会〔2006〕3 号）及《保险合同相关会计处理规定》（财会〔2009〕15 号），新华 人寿保险股份有限公司于 2023 年 1 月 1 日至 2023 年 8 月 31 日期间累计原保险 保费收入为人民币 12,786,123 万元。 特此公告。 新华人寿保险股份有限公司董事会 2023 年 9 月 11 日 ...

新華人壽保險股份有限公司 NEW CHINA LIFE INSURANCE CO., LTD. (於中華人民共和國註冊成立的股份有限公司) 股份代號: 01336 2023 中期報告 New China Insurance Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing 100022,P.R.C www.newchinalife.com 新華人壽保險股份有限公司 北京市朝陽區建國門外大街甲12號新華保險大廈 NEW CHINA LIFE INSURANCE CO., LTD. 全國統一客服電話 新華保險服務號 投資者關係網站 New China Life Insurance Company Ltd. 新華人壽保險股份有限公 司 中期報告 2023 重要 提示 新華人壽保險股份有限公司 1 1. 本公司董事會、監事會及董事、監事、高級管理人員保證中期報告內容的真實、準確、完整，不存在虛假記 載、誤導性陳述或重大遺漏，並承擔個別和連帶的法律責任。 2. 本公司第八屆董事會第九次會議於2023年8月29日審議通過了《2023年中期報告》。會議應 ...

Financial Reporting Standards - The company reported a mid-term financial summary based on IFRS 17 and IFRS 9, indicating adherence to international financial reporting standards [3]. - The financial statements were prepared in accordance with International Accounting Standard 34, ensuring compliance with relevant regulations [140]. - The review of the financial statements did not reveal any issues that would indicate non-compliance with International Accounting Standards [142]. - The group adopted IFRS 9 for financial instruments starting January 1, 2023, which introduced new classification and measurement requirements for financial assets and liabilities [158]. - The group adopted IFRS 17 for insurance contracts starting from January 1, 2023, leading to significant changes in accounting policies [181]. Board and Governance - The board of directors confirmed the accuracy and completeness of the mid-term report, with all 11 directors present at the meeting [3]. - The company’s board consists of 11 members, including executive and independent non-executive directors [103]. - The company held two shareholder meetings, six board meetings, and five supervisory board meetings during the reporting period, complying with regulatory requirements for announcements [99]. - The company confirmed that all directors, supervisors, and senior management adhered to the standards set forth in the "Standard Code" during the reporting period [101]. - The company has maintained compliance with the Corporate Governance Code and has adopted most of the recommended best practices [126]. Financial Performance - Total assets reached CNY 1,309.18 billion, with net profit attributable to shareholders at CNY 9.98 billion [12]. - The net profit attributable to shareholders was CNY 9.978 billion, reflecting an increase of 8.6% year-on-year [23]. - The company reported a net cash flow from operating activities of CNY 65.508 billion, which is a 15.3% increase compared to the same period last year [23]. - The total comprehensive income for the six months ended June 30, 2023, was RMB 1,338 million, a decrease from RMB 4,392 million in the prior year, reflecting a decline of approximately 69.6% [148]. - Basic earnings per share for the six months ended June 30, 2023, were RMB 3.20, up from RMB 2.95 in the same period of 2022, marking an increase of 8.5% [148]. Insurance Operations - The company reported a 5.1% year-on-year increase in original insurance premium income, totaling CNY 107.85 billion [14]. - The company processed a total of 2.07 million claims, with total payouts amounting to CNY 7.96 billion [20]. - The first-year premium for long-term insurance reached CNY 33.86 billion, up 14.8% year-on-year, while the first-year regular premium increased by 42.9% to CNY 17.48 billion [32]. - The company’s insurance service income was CNY 26.593 billion, down 6.5% from the previous year [26]. - The total insurance contract liabilities increased by 9.0% to CNY 1,103.982 billion compared to the end of 2022 [51]. Investment Activities - Investment scale reached CNY 1,259.16 billion, an increase of 8.8% from the end of the previous year [15]. - The annualized total investment return rate was 3.7%, with a net investment return rate of 3.4% [15]. - The total investment assets of the company amounted to CNY 1,259.159 billion as of June 30, 2023, representing an 8.8% increase from the end of the previous year [52]. - The company reported a significant loss in investment asset trading of (5,517) million, compared to a loss of (1,528) million in the previous year, marking a 261.1% increase in losses [56]. - The company has implemented various credit enhancement measures for non-standard assets, ensuring overall asset quality remains high and risks are low [58]. Risk Management - The company faces various risks including market risk, credit risk, insurance risk, operational risk, reputational risk, strategic risk, and liquidity risk, with measures in place to manage these risks effectively [3]. - The company emphasizes compliance and risk management to address potential risks in the current economic environment [74]. - The company has not engaged in non-operational fund occupation by controlling shareholders or related parties [3]. - The company has not violated decision-making procedures in providing guarantees [3]. - The company has not reported any significant litigation or arbitration issues as of June 30, 2023 [118]. Corporate Social Responsibility - The company allocated 9.4 million RMB in aid to Guizhou Province and 1 million RMB to Inner Mongolia for rural revitalization projects [113]. - The company has provided accident insurance coverage worth 10 million RMB to over 920,000 sanitation workers across nearly 170 cities [114]. - The company has a volunteer team of 44,094 members, conducting 1,649 volunteer activities with a total service time of 45,956.55 hours [114]. - The company has invested a total of 226.47 billion RMB in strategic emerging industries as of June 30, 2023 [112]. - The company achieved premium income of approximately 4 billion RMB from exclusive commercial pension insurance sales [112]. Shareholder Information - The total number of shares outstanding is 3,119,546,600, with 66.85% being A-shares and 33.15% being H-shares [128]. - The largest shareholder, Central Huijin Investment Ltd., holds 977,530,534 shares, representing 31.34% of the total shares [131]. - The company has no significant litigation or arbitration matters during the reporting period [124]. - There were no changes in the company's share capital structure during the reporting period [128]. - The company continues to fulfill its commitment to avoid competition with its controlling shareholder, Huijin Company [123].

致：香港交易及結算所有限公司 公司名稱: 新華人壽保險股份有限公司 呈交日期: 2023年9月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 | 01336 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,034,107,260 | RMB | | 1 RMB | | 1,034,107,260 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 | | | 1,034,107,260 | RMB | | 1 RMB | | 1,034,107,260 | | 2. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | ...